VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
TGTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
TGTXTG Therapeutics, Inc.
$55.72$8.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksTGTXQuarterly Financials

TG Therapeutics, Inc. (TGTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

TG Therapeutics, Inc. (TGTX) quarterly income statement — complete revenue, gross profit & net income history

TGTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue204.92M192.57M161.71M141.15M120.86M108.19M83.88M73.47M63.47M43.97M165.81M16.07M7.8M80K94K594K2.02M2.32M2.03M1.54M
Revenue Growth %69.56%78%92.79%92.13%90.4%146.04%-49.41%357.05%713.46%54863.75%176298.94%2606.06%287.05%-96.55%-95.37%-61.55%154.22%6007.89%5242.11%3965.79%
Cost of Goods Sold33.51M38.14M28.16M18.94M15.54M15.4M9.34M8.3M5.52M7.95M3.51M1.91M857K3K2K23K237K210K292K148K
COGS % of Revenue16.35%19.81%17.41%13.42%12.86%14.23%11.14%11.3%8.7%18.07%2.12%11.89%10.98%3.75%2.13%3.87%11.76%9.05%14.38%9.58%
Gross Profit171.41M154.43M133.55M122.21M105.31M92.79M74.54M65.16M57.95M36.02M162.31M14.16M6.95M77K92K571K1.78M2.11M1.74M1.4M
Gross Margin %83.65%80.19%82.59%86.58%87.14%85.77%88.86%88.7%91.3%81.93%97.88%88.11%89.02%96.25%97.87%96.13%88.24%90.95%85.62%90.42%
Gross Profit Growth %62.76%66.44%79.18%87.55%81.73%157.56%-54.08%360.09%734.31%46685.71%176319.57%2380.39%290.44%-96.35%-94.71%-59.13%172.02%3204.41%4473.68%3576.32%
Operating Expenses136.61M103.94M104.19M87.37M96.69M62.84M62.1M56.35M67.22M48.51M47.52M58.84M43.94M52.14M35.05M39.51M68.65M95.06M86.87M78.89M
OpEx % of Revenue66.67%53.97%64.43%61.9%80.01%58.08%74.04%76.7%105.9%110.32%28.66%366.04%563.09%65173.75%37292.55%6651.85%3405.31%4095.56%4279.11%5106.08%
Selling, General & Admin73.14M62.74M63.31M55.59M50.33M38.96M41.97M38.72M34.5M31.06M32.77M36.38M28.07M22.5M14.25M12.64M20.61M32.41M34.9M34.02M
SG&A % of Revenue35.69%32.58%39.15%39.38%41.65%36.02%50.03%52.7%54.35%70.64%19.76%226.32%359.71%28130%15163.83%2127.61%1022.27%1396.47%1719.16%2201.75%
Research & Development43.52M41.19M40.88M31.78M46.36M23.87M20.14M17.56M32.72M17.45M14.75M22.46M15.87M29.64M20.8M26.87M48.04M62.65M51.97M44.87M
R&D % of Revenue21.24%21.39%25.28%22.52%38.36%22.07%24.01%23.9%51.55%39.68%8.9%139.72%203.38%37043.75%22128.72%4524.24%2383.04%2699.1%2559.95%2904.27%
Other Operating Expenses1000K00000072K000000000001K
Operating Income34.8M50.49M29.36M34.84M8.62M29.95M12.43M8.82M-9.27M-12.48M114.78M-44.67M-36.99M-52.06M-34.96M-38.94M-66.87M-92.95M-85.13M-77.49M
Operating Margin %16.98%26.22%18.16%24.69%7.13%27.68%14.82%12%-14.6%-28.39%69.22%-277.93%-474.07%-65077.5%-37194.68%-6555.72%-3317.06%-4004.61%-4193.5%-5015.66%
Operating Income Growth %303.56%68.6%136.17%295.22%193.01%339.88%-89.17%119.73%74.94%76.02%428.3%-14.72%44.68%43.99%58.93%49.75%25.03%-7.1%0.69%-52.41%
EBITDA34.8M50.56M29.43M34.9M8.68M30.01M12.5M8.89M-9.19M-12.39M114.91M-44.59M-36.87M-51.94M-34.83M-38.81M-66.74M-92.81M-85M-77.37M
EBITDA Margin %16.98%26.26%18.2%24.73%7.18%27.74%14.9%12.1%-14.48%-28.19%69.3%-277.4%-472.52%-64920%-37057.45%-6533.67%-3310.66%-3998.88%-4187.14%-5007.9%
EBITDA Growth %300.96%68.47%135.45%292.69%194.45%342.14%-89.12%119.93%75.08%76.14%429.88%-14.89%44.76%44.04%59.02%49.84%25.08%-7.08%0.73%-52.44%
D&A (Non-Cash Add-back)067K62K59K56K62K64K72K82K91K126K85K121K126K129K131K129K133K129K120K
EBIT34.8M51.63M32.63M37.64M12.22M32.51M15.1M10.53M-8.39M-11.6M117.64M-43.98M-36.39M-50.13M-34.17M-37.49M-66.35M-92.26M-84.6M-76.87M
Net Interest Income-7.67M-6.53M-6.72M-6.72M-6.76M-7.06M-10.83M-3.98M-2.29M-2.43M-3.71M-3.63M-2.84M-2.86M-1.65M-3.02M-2.66M-1.08M-1.04M-1.62M
Interest Income00000000000000000000
Interest Expense7.67M6.53M6.72M6.72M6.76M7.06M10.83M3.98M2.29M2.43M3.71M3.63M2.84M2.86M1.65M3.02M2.66M1.08M1.04M1.62M
Other Income/Expense-14.43M-5.4M-3.46M-3.92M-3.15M-4.5M-8.17M-2.27M-1.41M-1.54M-854K-2.94M-2.24M-932K-855K-1.57M-2.14M-391K-509K-1M
Pretax Income20.36M45.09M25.91M30.92M5.47M25.45M4.27M6.55M-10.68M-14.03M113.93M-47.61M-39.23M-52.99M-35.82M-40.51M-69.01M-93.34M-85.64M-78.5M
Pretax Margin %9.94%23.42%16.02%21.91%4.52%23.53%5.09%8.92%-16.82%-31.9%68.71%-296.19%-502.78%-66242.5%-38104.26%-6819.87%-3423.26%-4021.46%-4218.57%-5080.65%
Income Tax-586K22.06M-364.99M2.73M408K2.12M388K-328K29K390K0000000000
Effective Tax Rate %-2.88%48.91%-1408.72%8.84%7.46%8.34%9.09%-5.01%-0.27%-2.78%0%0%0%0%0%0%0%0%0%0%
Net Income19.78M23.04M390.89M28.19M5.06M23.33M3.88M6.88M-10.71M-14.42M113.93M-47.61M-39.23M-52.99M-35.82M-40.51M-69.01M-93.34M-85.64M-78.5M
Net Margin %9.65%11.96%241.73%19.97%4.19%21.57%4.63%9.36%-16.87%-32.79%68.71%-296.19%-502.78%-66242.5%-38104.26%-6819.87%-3423.26%-4021.46%-4218.57%-5080.71%
Net Income Growth %290.85%-1.26%9974.61%309.75%147.26%261.84%-96.59%114.45%72.71%72.8%418.08%-17.53%43.15%43.22%58.17%48.39%23.85%-5.8%1.75%-48.43%
Net Income (Continuing)19.78M23.04M390.89M28.19M5.06M23.33M3.88M6.88M-10.71M-14.42M113.93M-47.61M-39.23M-52.99M-35.82M-40.51M-69.01M-93.34M-85.64M-78.5M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)0.120.142.430.170.030.150.020.04-0.07-0.100.73-0.34-0.28-0.39-0.26-0.30-0.51-0.70-0.65-0.59
EPS Growth %285.85%-6.67%12050%293.52%142.49%250%-97.26%112.71%73.86%74.36%380.77%-13.33%45.1%44.29%60%49.15%26.09%1.41%10.96%-25.53%
EPS (Basic)0.140.162.690.190.030.160.030.05-0.07-0.100.80-0.34-0.28-0.39-0.26-0.30-0.51-0.70-0.65-0.59
Diluted Shares Outstanding160.06M159.37M161M162.56M162.77M160.24M160.71M159.42M146.21M143.09M155.87M141.5M140.31M137.11M135.33M137.78M134.4M132.56M132.35M132.07M
Basic Shares Outstanding144.44M142.96M145.42M146.74M146.68M145.24M145.1M144.73M146.21M143.09M142.87M141.5M140.31M137.11M135.33M137.78M134.4M132.56M132.35M132.07M
Dividend Payout Ratio--------------------